Among 7 analysts covering JM Smucker (NYSE:SJM), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. JM Smucker had 16 analyst reports since January 23, 2019 according to SRatingsIntel. Morgan Stanley maintained The J. M. Smucker Company (NYSE:SJM) on Friday, June 7 with “Equal-Weight” rating. Morgan Stanley maintained the stock with “Underweight” rating in Wednesday, February 27 report. The stock has “Market Perform” rating by Wells Fargo on Monday, February 25. On Wednesday, February 27 the stock rating was maintained by Credit Suisse with “Underperform”. The stock of The J. M. Smucker Company (NYSE:SJM) has “Neutral” rating given on Monday, April 8 by Credit Suisse. The stock of The J. M. Smucker Company (NYSE:SJM) has “Hold” rating given on Wednesday, February 27 by Barclays Capital. Wells Fargo maintained the shares of SJM in report on Friday, June 7 with “Market Perform” rating. The stock of The J. M. Smucker Company (NYSE:SJM) has “Buy” rating given on Wednesday, February 27 by Citigroup. As per Tuesday, February 26, the company rating was maintained by Jefferies. See The J. M. Smucker Company (NYSE:SJM) latest ratings:
07/06/2019 Broker: Wells Fargo Rating: Market Perform Old Target: $110.0000 New Target: $114.0000 Maintain
07/06/2019 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $117.0000 New Target: $120.0000 Maintain
14/05/2019 Broker: BidaskScore Rating: Buy Upgrade
01/05/2019 Broker: BidaskScore Rating: Buy Upgrade
18/04/2019 Broker: Morgan Stanley Old Rating: Underweight New Rating: Equal-Weight Upgrade
08/04/2019 Broker: Credit Suisse Old Rating: Underperform New Rating: Neutral Old Target: $96 New Target: $120 Upgrade
01/04/2019 Broker: Argus Research Rating: Hold Initiates Coverage On
07/03/2019 Broker: BidaskScore Rating: Sell Downgrade
27/02/2019 Broker: Barclays Capital Rating: Hold New Target: $108 Maintain
27/02/2019 Broker: Morgan Stanley Old Rating: Underweight New Rating: Underweight Old Target: $98 New Target: $104 Maintain
Cambridge Trust Company decreased Johnson & Johnson (JNJ) stake by 1.31% reported in 2019Q1 SEC filing. Cambridge Trust Company sold 3,749 shares as Johnson & Johnson (JNJ)’s stock rose 1.83%. The Cambridge Trust Company holds 282,222 shares with $39.45 million value, down from 285,971 last quarter. Johnson & Johnson now has $376.17B valuation. The stock increased 1.36% or $1.9 during the last trading session, reaching $141.68. About 8.87M shares traded or 32.49% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 8.61% since June 13, 2018 and is uptrending. It has outperformed by 4.18% the S&P500. Some Historical JNJ News: 16/04/2018 – BOEHRINGER, LILLY, OXFORD TO INVESTIGATE JARDIANCE; 06/04/2018 – Johnson & Johnson Vision Highlights New Data, Educational Resources and Support for the Ophthalmology Community at the 2018 ASCRS•ASOA Annual Meeting; 07/05/2018 – Moody’s assigns B2 CFR to LifeScan Global Corporation; 16/04/2018 – JANSSEN ANNOUNCES WORLDWIDE DEVELOPMENT & COMMERCIALIZATION COLLABORATION WITH BRISTOL-MYERS TO ADVANCE THERAPY FOR CARDIOVASCULAR DISEASES; 17/04/2018 – J&J – EXCLUDING NET IMPACT OF ACQUISITIONS AND DIVESTITURES, ON AN OPERATIONAL, QTRLY BASIS DOMESTIC SALES INCREASED 1.3%; 07/03/2018 – CANADIAN NATIONAL RAILWAY CO – INTERIM PRESIDENT, CEO JJ RUEST SAID CO IS DIRECTING ADDITIONAL PEOPLE, EQUIPMENT TO CLEAR BACKLOGS ACROSS ITS NETWORK; 12/04/2018 – INVOKANA® (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease; 06/03/2018 – ELI LILLY AND CO – EMPERIAL TRIALS TO EVALUATE EFFECT OF JARDIANCE ON EXERCISE ABILITY, HEART FAILURE SYMPTOMS IN PEOPLE WITH CHRONIC HEART FAILURE; 11/04/2018 – J&J: One-of-a-Kind Contact Lens Corrects Vision and Adapts to Changing Light Conditions; 17/04/2018 – Johnson & Johnson Backs 2018 View of Adj EPS $8.00-Adj EPS $8.20
Cambridge Trust Company increased Hcp Inc (NYSE:HCP) stake by 21,251 shares to 275,890 valued at $8.64M in 2019Q1. It also upped Activision Blizzard Inc. (NASDAQ:ATVI) stake by 21,535 shares and now owns 90,803 shares. Royal Dutch was raised too.
Among 7 analysts covering Johnson \u0026 Johnson (NYSE:JNJ), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Johnson \u0026 Johnson had 15 analyst reports since January 2, 2019 according to SRatingsIntel. On Monday, March 25 the stock rating was maintained by Raymond James with “Buy”. Credit Suisse maintained the shares of JNJ in report on Wednesday, April 17 with “Outperform” rating. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Cowen & Co on Wednesday, March 6. Citigroup maintained it with “Neutral” rating and $147 target in Monday, February 25 report. Citigroup maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, January 2. Citigroup has “Neutral” rating and $139 target. Wells Fargo maintained the stock with “Outperform” rating in Monday, January 14 report. The firm earned “Equal-Weight” rating on Wednesday, April 17 by Morgan Stanley. The company was maintained on Wednesday, April 17 by Raymond James. The stock has “Outperform” rating by BMO Capital Markets on Wednesday, April 17. The firm earned “Outperform” rating on Thursday, May 16 by Credit Suisse.
Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 16. They expect $2.42 earnings per share, up 15.24% or $0.32 from last year’s $2.1 per share. JNJ’s profit will be $6.43B for 14.64 P/E if the $2.42 EPS becomes a reality. After $2.10 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 15.24% EPS growth.
Since December 14, 2018, it had 1 insider purchase, and 0 selling transactions for $419,040 activity. On Friday, December 14 PRINCE CHARLES bought $268,731 worth of Johnson & Johnson (NYSE:JNJ) or 2,000 shares. Shares for $419,040 were bought by HEWSON MARILLYN A on Tuesday, June 11. PEREZ WILLIAM D also bought $133,910 worth of Johnson & Johnson (NYSE:JNJ) on Friday, December 14. MULCAHY ANNE M bought $100,050 worth of stock or 748 shares.
Investors sentiment decreased to 0.84 in Q1 2019. Its down 0.02, from 0.86 in 2018Q4. It turned negative, as 57 investors sold JNJ shares while 837 reduced holdings. 129 funds opened positions while 620 raised stakes. 1.84 billion shares or 2.89% more from 1.79 billion shares in 2018Q4 were reported. Architects has 0.94% invested in Johnson & Johnson (NYSE:JNJ) for 3,839 shares. Mason Street Advsrs holds 1.1% or 379,932 shares in its portfolio. Bryn Mawr Tru owns 288,892 shares for 2.2% of their portfolio. Fidelity National Fincl Incorporated stated it has 1.29% of its portfolio in Johnson & Johnson (NYSE:JNJ). Birinyi Associates Inc owns 9,450 shares. Canal Insurance stated it has 3.33% of its portfolio in Johnson & Johnson (NYSE:JNJ). Bridgecreek Investment Llc, a Oklahoma-based fund reported 10,535 shares. Factory Mutual invested in 1.5% or 936,800 shares. Envestnet Asset Mgmt Incorporated, a Illinois-based fund reported 1.09M shares. Massachusetts Ser Ma, a Massachusetts-based fund reported 28.15 million shares. Blackrock has 188.89 million shares for 1.18% of their portfolio. Greenwood Gearhart holds 2.7% or 65,784 shares. Sit Invest Associate invested in 1.23% or 278,015 shares. Moreover, Lvw Advsr Lc has 1.17% invested in Johnson & Johnson (NYSE:JNJ). Fifth Third Bank reported 1.12% stake.
More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Finance.Yahoo.com which released: “Should You Be Holding Johnson & Johnson (NYSE:JNJ)? – Yahoo Finance” on June 07, 2019, also Seekingalpha.com with their article: “Johnson & Johnson – Experiencing Buyer’s Remorse – Johnson & Johnson (NYSE:JNJ) – Seeking Alpha” published on June 02, 2019, Streetinsider.com published: “J&J (JNJ), Colgate-Palmolive (CL) Ordered to Pay About $12M in Talc-Cancer Case – Bloomberg; Jury Decided Against Awarding Punitive Damages – StreetInsider.com” on June 12, 2019. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Benzinga.com and their article: “Johnson & Johnson Analyst: 3 Takeaways On Opioid Litigation – Benzinga” published on May 30, 2019 as well as Seekingalpha.com‘s news article titled: “J&J down 6% on Oklahoma opioid litigation – Seeking Alpha” with publication date: May 29, 2019.
The J. M. Smucker Company manufactures and markets branded food and beverage products worldwide. The company has market cap of $14.09 billion. It operates through U.S. It has a 27.4 P/E ratio. Retail Coffee, U.S.
Since December 18, 2018, it had 2 buys, and 1 insider sale for $1.03 million activity. $1.08M worth of The J. M. Smucker Company (NYSE:SJM) was bought by SMUCKER TIMOTHY P. $94,571 worth of stock was sold by Lemmon David J on Monday, December 31. DINDO KATHRYN W bought $46,100 worth of stock or 500 shares.
Investors sentiment increased to 1.29 in 2019 Q1. Its up 0.53, from 0.76 in 2018Q4. It improved, as 40 investors sold The J. M. Smucker Company shares while 187 reduced holdings. 98 funds opened positions while 194 raised stakes. 85.29 million shares or 4.95% less from 89.73 million shares in 2018Q4 were reported. Valley Advisers has invested 0% of its portfolio in The J. M. Smucker Company (NYSE:SJM). Tarbox Family Office reported 0.19% stake. Virginia Retirement Systems Et Al accumulated 168,000 shares or 0.23% of the stock. Moreover, Citigroup Inc has 0.01% invested in The J. M. Smucker Company (NYSE:SJM). Keybank Association Oh invested 0.05% of its portfolio in The J. M. Smucker Company (NYSE:SJM). Qs Investors Limited Liability Company holds 0.03% or 20,385 shares in its portfolio. Regions Corp holds 5,714 shares or 0.01% of its portfolio. Ancora Advsr Limited Liability Corporation reported 39,260 shares or 0.19% of all its holdings. Canada Pension Plan Inv Board has 0% invested in The J. M. Smucker Company (NYSE:SJM) for 1,474 shares. Roberts Glore Il holds 2,978 shares. Gulf Retail Bank (Uk) Ltd holds 0.05% in The J. M. Smucker Company (NYSE:SJM) or 24,207 shares. 7,912 are held by Lenox Wealth Mngmt. Parametric Associates holds 799,577 shares. Centurylink Co stated it has 0.58% of its portfolio in The J. M. Smucker Company (NYSE:SJM). Wetherby Asset Mgmt Inc holds 1,758 shares.
The stock increased 0.61% or $0.75 during the last trading session, reaching $123.86. About 726,912 shares traded. The J. M. Smucker Company (NYSE:SJM) has risen 14.27% since June 13, 2018 and is uptrending. It has outperformed by 9.84% the S&P500. Some Historical SJM News: 05/03/2018 – CONAGRA BRANDS INC – ARE WORKING WITH J.M. SMUCKER COMPANY TO REVIEW ALL OPTIONS REGARDING PROPOSED SALE OF WESSON OIL BUSINESS; 04/04/2018 – J M SMUCKER – POST EFFECT OF FIRST YR OF SYNERGIES, EXPECTS ACQUIRED BUSINESS TO CONTRIBUTE ABOUT $0.25 OF ACCRETION TO CO’S ADJUSTED SHR; 22/03/2018 – J M SMUCKER – FDA INFORMED SMUCKER OF THREE ILLNESS REPORTS, CO INITIATED VOLUNTARY RECALL OF DOG TREATS; 04/04/2018 – J.M. Smucker: Annual Cost Synergies of $55 Million Expected Within First Three Years After Acquisition; 24/05/2018 – FOSSIL GROUP INC – BELGYA CURRENTLY SERVES AS VICE CHAIR AND CHIEF FINANCIAL OFFICER OF J.M. SMUCKER COMPANY; 05/03/2018 – JM Smucker: Disappointed With FTC Conclusion, Believe Acquisition Would Benefit All Constituents; 09/03/2018 – Chicago Brkg Biz: Smucker’s Pillsbury, baking brands said to be for sale; 06/03/2018 – US challenges JM Smucker’s purchase of Conagra’s Wesson oil brand; 22/03/2018 – J.M. Smucker: FDA Informed Company of Three Illness Reports; 06/03/2018 – CONAGRA BRANDS & J.M. SMUCKER CO. TERMINATE PACT FOR WESSON OIL
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.